UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040863
Receipt number R000044381
Scientific Title The effects of a combination agent of perilla oil and natural product-derived functional substrates on body composition, hematological and biological blood parameters in the elderly
Date of disclosure of the study information 2020/06/23
Last modified on 2021/04/15 15:14:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of a combination agent of perilla oil and natural product-derived functional substrates on body composition, hematological and biological blood parameters in the elderly

Acronym

The effects of a combination agent of perilla oil and natural product-derived functional substrates on body composition, hematological and biological blood parameters in the elderly

Scientific Title

The effects of a combination agent of perilla oil and natural product-derived functional substrates on body composition, hematological and biological blood parameters in the elderly

Scientific Title:Acronym

The effects of a combination agent of perilla oil and natural product-derived functional substrates on body composition, hematological and biological blood parameters in the elderly

Region

Japan


Condition

Condition

The adult and elderly

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Soft capsules containing perilla oil containing 60% of alpha-linolenic acid, an omega-3 fatty acid, and AD blue poncan powder containing 0.28% of nobiletin or Anredera cordifolia leaf dry powder, which is a functional substance derived from natural products. The main purpose of this study is to examine the effects of chronic administration of these soft capsules on the safety and the health of the adult and elderly.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood biochemical items, Health condition

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Perilla oil

Interventions/Control_2

12 months

Interventions/Control_3

capsules

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

. The age at consent 40 years old over and 85 years old or younger.
. The cognitive function test value at the start of the test satisfies all of the following.
Total MMSE score is 22 points or more.
Total HDS-R scores is 21 points or more.
. Agreement has been obtained from the principal concerning research participation in writing.
. Conversation in Japanese is possible.

Key exclusion criteria

.Development of dementia and osteoporosis.
.Use a antipsychotics, dementia treatment drugs, anticoagulants and antiplatelet drugs.
. Taking drugs containing linolenic acid, EPA and/or DHA, and supplements that expected to improve brain function and serum lipid levels.
.Taking osteoporosis remedies and supplements that are expected to improve bones.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Michio
Middle name
Last name Hashimoto

Organization

Shimane University

Division name

Faculty of Medicine, Department of Environmental Physiology

Zip code

693-8501

Address

89-1, Enyacho, Izumo, Shimane 693-8501, Japan

TEL

0853-20-2730

Email

michio1@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name Michio
Middle name
Last name Hashimoto

Organization

Shimane University

Division name

Faculty of Medicine, Department of Environmental Physiology

Zip code

693-8501

Address

89-1, Enyacho, Izumo, Shimane 693-8501, Japan

TEL

0853-20-2730

Homepage URL


Email

michio1@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University

Institute

Department

Personal name



Funding Source

Organization

Sankyo Holdings Co., Ltd.,

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiamne University

Address

89-1 Enyachou, Izumo, Shimane 693-8501, Japan

Tel

0853-20-2730

Email

michio1@med.shimane-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 23 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

102

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 05 Month 21 Day

Date of IRB

2018 Year 05 Month 21 Day

Anticipated trial start date

2018 Year 08 Month 01 Day

Last follow-up date

2020 Year 08 Month 30 Day

Date of closure to data entry

2021 Year 01 Month 30 Day

Date trial data considered complete

2021 Year 02 Month 20 Day

Date analysis concluded

2021 Year 03 Month 10 Day


Other

Other related information



Management information

Registered date

2020 Year 06 Month 23 Day

Last modified on

2021 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044381


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name